Cytek BioSciences Inc

Cytek BioSciences Inc

CTKB

Get informed when a big investor buys or sells

+ Follow
Market Cap$486.87M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cytek BioSciences IncCytek BioSciences Inc-6.5--23%4.10.1
$5.13

Target Price by Analysts

25.9% upsideCytek BioSciences Target Price DetailsTarget Price
$0.20

Current Fair Value

95.1% downside

Overvalued by 95.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$486.87 Million
Enterprise Value$465.06 Million
Dividend Yield$- (-)
Earnings per Share$-0.52
Beta1.19
Outstanding Shares128,704,934

Return

Return on Equity-22.59%ROE
Return on Assets-16.48%
Return on Invested Capital-11.29%

Valuation & Multiples

P/E Ratio-6.53P/E Ratio
PEG-9.98PEG
Price to Sales4.07Price to Sales
Price to Book Ratio2.04Price to Book Ratio
Enterprise Value to Revenue2.28
Enterprise Value to EBIT-11.18
Enterprise Value to Net Income-7
Total Debt to Enterprise0.09
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$44.23 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$-0.01
Average shareholder expectation
Revenue Estimate
$48.61 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls11,500▲ Infinity%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %66.59%▲ 2.28%
Total Invested$371.77M▼ 10.26%
Investors Holding165▲ 11.00%

ESG Score

No data

About Cytek BioSciences Inc

2,021 employees